Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial

Barraud, Damien; Blard, Claire; Hein, François; Marçon, Olivier; Cravoisy, Aurélie; Nace, Lionel; Alla, François; Bollaert, Pierre-Edouard; Gibot, Sébastien
September 2010
Intensive Care Medicine;Sep2010, Vol. 36 Issue 9, p1540
Academic Journal
Probiotics have been shown to be able to restore a non-pathogenic digestive flora, to prevent digestive colonization by pathogenic bacteria, and to modulate immunity. The aim of this study was to assess the effects of prophylactic probiotic administration in patients ventilated for up to 2 days. This study was performed as a double-blind, concealed randomized, placebo-controlled trial in a French medical intensive care unit (ICU). Adult patients mechanically ventilated for a period of more than 48 h received enterally administered probiotics ( Ergyphilus®, 2 × 1010 lactic acid bacteria, mostly Lactobacillus rhamnosus GG, once a day) or placebo until successful weaning. A total of 167 patients were included. The two groups were comparable at baseline. The 28-day mortality rates were not different in the probiotic (25.3%) and placebo groups (23.7%). Mortality rates in ICU and at 90 days were also unaffected by the treatment. The incidence of ICU-acquired infections did not differ significantly except for that of catheter-related bloodstream infections that was lowered by probiotics. On a prespecified subgroup analysis, we found a reduction of the 28-day mortality among severe sepsis patients (total n = 101) treated with probiotics ( n = 52) with an odds ratio (OR) for death at 0.38 (95% CI 0.16–0.93, p = 0.035). By contrast, probiotics were associated with a higher mortality rate in non-severe sepsis patients (OR 3.09, 95% CI 0.87–11.01, p = 0.08). Although numerous uncertainties remain (type and the number of strains to use, delay and length of administration), and despite an acceptable safety profile, the daily prophylactic administration of probiotics cannot be encouraged in the critically ill patient.


Related Articles

  • Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. Zarychanski, Ryan; Turgeon, Alexis F.; McIntyre, Lauralyn; Fergusson, Dean A. // CMAJ: Canadian Medical Association Journal;9/25/2007, Vol. 177 Issue 7, p725 

    Introduction: Anemia and the need for red blood cell transfusions are common among patients admitted to intensive care units. Erythropoietin has been used to decrease the need for transfusions; however, its ability to improve clinical outcomes is unknown. We evaluated the effect of...

  • Rationale and study design of ViPS -- variable pressure support for weaning from mechanical ventilation: study protocol for an international multicenter randomized controlled open trial. Kiss, Thomas; Uhlig, Christopher; Spieth, Peter Markus; Markstaller, Klaus; Ullrich, Roman; Jaber, Samir; Santos, Jose Alberto; Mancebo, Jordi; Camporota, Luigi; Beale, Richard; Schettino, Guilherme; Saddy, Felipe; Vallverdú, Immaculada; Wiedemann, Bärbel; Koch, Thea; Schultz, Marcus Josephus; Pelosi, Paolo; de Abreu, Marcelo Gama // Trials;2013, Vol. 14 Issue 1, p1 

    Background In pressure support ventilation (PSV), a non-variable level of pressure support is delivered by the ventilator when triggered by the patient. In contrast, variable PSV delivers a level of pressure support that varies in a random fashion, introducing more physiological variability to...

  • Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: the Acute Neurological ICU Sedation Trial (ANIST). Mirski, Marek A.; Lewin III, John J.; LeDroux, Shannon; Thompson, Carol; Murakami, Peter; Zink, Elizabeth K.; Griswold, Michael // Intensive Care Medicine;Sep2010, Vol. 36 Issue 9, p1505 

    Most anxiolytics and sedative regimens in the intensive care unit (ICU) impair intellectual function, reducing patient autonomy, and often add to patient morbidity. Using an ICU-validated cognitive assessment tool Adapted Cognitive Exam (ACE), we performed a comparison between dexmedetomidine...

  • The effect of waiving consent on enrollment in a sepsis trial. Annane, Djillali; Outin, Hervé; Fisch, Caroline; Bellissant, Eric // Intensive Care Medicine;Feb2004, Vol. 30 Issue 2, p321 

    Objective. Illustration of the difficulties in approaching critically ill patients for informed consent for inclusion into a randomized controlled trial and the impact of a waiver of consent from the patient’s next of kin in the conduction of such studies. Design. Descriptive survey of...

  • Research Review. Thomas, Margot // Dynamics;Fall2006, Vol. 17 Issue 3, p11 

    The article discusses the research entitled "Gastric feeding in critically ill children: A randomized controlled trial," by D. Horn and W. Chaboyer. The objective of the research is to study the relationship of gastric feeding regimens with patient tolerance. The research was conducted in a...

  • Management with a pulmonary artery catheter did not reduce all-cause mortality in critically ill patients.  // ACP Journal Club;Jan/Feb2006, Vol. 144 Issue 1, p21 

    This article comments on a study conducted to examine the efficacy of pulmonary artery catheter (PAC) in reducing all-cause mortality in critically ill patients. Randomized controlled trial was conducted on 1041 patients admitted to an adult intensive care unit (ICU) who were identified by the...

  • Haloperidol prophylaxis in critically ill patients with a high risk for delirium. van den Boogaard, Mark; Schoonhoven, Lisette; van Achterberg, Theo; Van der Hoeven, Johannes G.; Pickkers, Peter // Critical Care;2013, Vol. 17 Issue 1, p1 

    Introduction: Delirium is associated with increased morbidity and mortality. We implemented a delirium prevention policy in intensive care unit (ICU) patients with a high risk of developing delirium, and evaluated if our policy resulted in quality improvement of relevant delirium outcome...

  • Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial. Girardis, Massimo; Busani, Stefano; Damiani, Elisa; Donati, Abele; Rinaldi, Laura; Marudi, Andrea; Morelli, Andrea; Antonelli, Massimo; Singer, Mervyn // JAMA: Journal of the American Medical Association;10/18/2016, Vol. 316 Issue 15, p1583 

    Importance: Despite suggestions of potential harm from unnecessary oxygen therapy, critically ill patients spend substantial periods in a hyperoxemic state. A strategy of controlled arterial oxygenation is thus rational but has not been validated in clinical practice....

  • CLINICAL PREDICTIVE VALUE OF THE MEDICAL RESEARCH COUNCIL SUMSCORE IN CRITICALLY ILL PATIENTS. Connolly, B.; Curtis, A.; Jones, G.; Murphy, P.; Moxham, J.; Hart, N. // Thorax;Dec2011 Supplement, pA95 

    Introduction Manual muscle testing, in the form of the Medical Research Council sumscore (MRC-SS) is a widely accepted clinical tool for diagnosing intensive care unit-acquired weakness (ICU-AW). Although MRC-SS is a simple bedside test, the nature of the test is volitional limiting its ability...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics